Immunizing Schedules for Hybridoma Production
Immunization protocols for generating activated B-lymphocytes suitable for hybridoma production vary widely. The optimal amount of antigen given, the way of antigen presentation, and the timing between injections must be determined for each antigen. Often, the antigen of interest is not available in a pure form, and the influence of contaminating antigens in the preparation should be considered when the immunization schedule is designed. Generally, a lower immunization dose will give rise to antibodies with higher specificity as compared to the total antibody response obtained after immunization with higher doses. Furthermore, antibodies obtained after one or two injections often show lower affinity than those obtained when a prolonged immunization schedule is used. The number of antibody-producing hybridomas obtained after fusing B-lymphocytes with myeloma cells depends on how well the mouse was immunized, and it is therefore worthwhile to put some effort into optimizing the immunization schedule.
- Oocytes as an Expression System for Studying Receptor/Channel Targets of Drugs and Pesticides
- 肿瘤发生(tumorigenesis)
- Monitoring MicroRNA Expression During Embryonic Stem-Cell Differentiation Using Quantitative Real-Time PCR (qRT-PCR)
- Purification of Native Bone Marrow Megakaryocytes for Studies of Gene Expression
- Methods for Data Analysis
- DelsGate: A Robust and Rapid Method for Gene Deletion
- Adult Neural Stem Cells
- Isolation and Culture of Hair Follicle Pluripotent Stem (hfPS) Cells and Their Use for Nerve and Spinal Cord Regeneration
- Computational Prediction of RNA Structural Motifs Involved in Post-Transcriptional Regulatory Processes
- 哺乳动物MAPK信号通路途径图